| 注册
首页|期刊导航|临床误诊误治|参灵方防治佐剂性关节炎大鼠药源性胃黏膜损伤的实验研究

参灵方防治佐剂性关节炎大鼠药源性胃黏膜损伤的实验研究

赵存方 李振彬 张岩岩 麻继臣 董魁星

临床误诊误治2011,Vol.24Issue(4):82-85,封3,5.
临床误诊误治2011,Vol.24Issue(4):82-85,封3,5.

参灵方防治佐剂性关节炎大鼠药源性胃黏膜损伤的实验研究

An Experimental Study of Shenling Decoction in Prevention of Drug - Induced Gastric Mucosa Injury in Adjuvant Arthritis Rats

赵存方 1李振彬 1张岩岩 1麻继臣 1董魁星1

作者信息

  • 1. 050082,石家庄,解放军白求恩国际和平医院干部病房一区
  • 折叠

摘要

Abstract

Objective To investigate the effect of Shenling decoction against drug-induced gastric mucosa injury in adjuvant arthritis(AA) rats. Methods The complex rat models of AA and drug damage were rendered. After 2 times of reaction, 48 rat models were randomly selected and divided into 7 groups: model group, compound model group, Ranitidine group,Shenling decoction low-dose group, Shenling decoction middle-dose group, Shenling decoction high-dose group, and blank control group (8 each ). Ranitidine group underwent intragastric administration treatment with Ranitidine at a dosage of 30 mg/( kg · d), and Shenling decoction low-dose group, Shenling decoction middle-dose group, Shenling decoction high-dose group underwent intragastric administration treatment with Shenling decoction at different doses of 3.5 g, 7 g, 14 g/(kg · d) respectively. Blank control group, model group and compound model group were given isometric 0. 9% sodium chloride injection. All the groups were treated for 14 days. Tumescence incident and index of foot and claw, and gastric mucosa injury index and inhibition ratio, and the pathologic changes were compared before and after treatment. Results There was no significant difference in joint tumescence incidents and indexes among model group, compound model group, Ranitidine group and Shenling treatment groups before and after treatment(P >0.05). When compared with that in the blank control group, tumescence incident of foot and claw in the other groups showed significant difference before and after treatment(P <0. 05); the foot volume and arthritis index in the groups treated with Shenling decoction were lower than those in model group and compound model group without significant difference ( P > 0. 05 ). When compared with that in the compound model group, the gastric mucosa danage index in Ranitidine group, Shenling decoction low-dose group, Shenling decoction middle-dose group, Shenling decoction high-dose group showed significant difference(P < 0.01 ), but there was no significant difference among Shenling decoction middle-dose group, Shenling decoction high-dose group and Ranitidine group( P > 0.05 ). There was significant difference of gastric mucosa damage index between Shenling decoction high-dose group and Ranitidine group (P <0.05). Inhibition ratios of gastric mucosa damage in Ranitidine group, Shenling decoction low-dose group, Shenling decoction middle-dose group, and Shenling decoction high-dose group were 74. 05%, 66. 81%, 74.41%, and 55.70% respectively, and there ws significant difference among the groups( P < 0. 05). Conclusion Shenling decoction has protective efficacy on the drug gastric mucosa injury without significant adverse effect on AA rat's joints.

关键词

参灵方/大鼠,Wistar/关节炎,实验性/胃黏膜/创伤和损伤

Key words

Shenling decoction/ Rat, Wistar/ Arthritis, experimental/ Gastric mucosa/ Wound and injury

分类

医药卫生

引用本文复制引用

赵存方,李振彬,张岩岩,麻继臣,董魁星..参灵方防治佐剂性关节炎大鼠药源性胃黏膜损伤的实验研究[J].临床误诊误治,2011,24(4):82-85,封3,5.

临床误诊误治

OACSTPCD

1002-3429

访问量0
|
下载量0
段落导航相关论文